Department of Hematology
血液科 · China-Japan Friendship Hospital, Beijing
Established in 1984, the Department of Hematology provides diagnosis and treatment for blood system diseases. The department utilizes MICM precise diagnosis for risk stratification and prognosis assessment. Treatment options include immunochemotherapy, targeted therapy, cell therapy, radiotherapy, and hematopoietic stem cell transplantation. Specialized clinics are available for plasma cell disorders, lymphoma, myelodysplastic syndromes, and leukemia. The department serves as a clinical trial base for new drugs and a training base for myelodysplastic syndromes. It maintains an independent bone marrow aspiration room and laboratory equipped with flow cytometry and PCR instruments to support accurate diagnostic procedures.
Conditions and treatments
- Treatment of lymphoma and plasma cell disorders
- Management of myelodysplastic syndromes and leukemia
- Hematopoietic stem cell transplantation
- Targeted therapy and immunochemotherapy
- Diagnosis of unexplained cytopenia and aplastic anemia
- Care for hemophagocytic syndrome
Key facts
- The department was established in 1984.
- There are 54 inpatient beds, including 2 dedicated transplantation beds.
- Annual outpatient volume is 20,000 visits, with 2,600 discharges.
Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.
| Specialty | Hematology |
|---|---|
| Doctors listed | 13 |
| Chief physicians | — |
Senior doctors
Chief and associate chief physicians listed for this department on public doctor-listing platforms (2025–2026).
Associate chief physicians
- Yayue Gao高亚玥
We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.
Need a specialist's opinion?
Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.
Contact us